New injectable HIV prevention program aims to protect latine communities
NCT ID NCT07218211
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a long-acting injectable PrEP (lenacapavir) program designed specifically for Latine gay, bisexual men and transgender women. Researchers want to see if offering the shots at community organizations helps more people stay on HIV prevention compared to standard clinic care. The study involves 100 HIV-negative participants in the southern U.S. and focuses on identifying barriers and facilitators to PrEP use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- lenacapavir (long-acting injectable PrEP)
- What this could lead to
- If successful, this program could make it easier for Latine gay, bisexual men and transgender women to stay on HIV prevention, reducing new infections in these communities.
- What could go wrong
- This is a small, early-phase study (100 participants) comparing to historical data, not a randomized trial. Results may not apply broadly, and long-term adherence remains uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PRE-EXPOSURE PROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
El Centro Hispano
RECRUITINGDurham, North Carolina, 27701, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app curb HIV risk in south Korea's young gay men?
- Can a conversation prevent HIV? study tests In-Person vs. online counseling for PrEP uptake
- Could a simple app help pharmacists stop HIV?
- New counseling approach aims to boost HIV prevention in young black men who have sex with men
- New HIV vaccine strategy aims to prime and boost immune defenses
- Can a tailored program help young men overcome stigma and test for HIV on their own terms?